{"name":"Kineta","permalink":"kineta","crunchbase_url":"http://www.crunchbase.com/company/kineta","homepage_url":"http://www.kinetabio.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":12,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"Lecura","email_address":"info@kinetabio.com","phone_number":"(206) 378-0400","description":"Disease Treatment","created_at":"Fri Jan 08 00:00:54 UTC 2010","updated_at":"Sat Jan 23 20:35:46 UTC 2010","overview":"<p>Kineta is a team of scientists dedicated to further study of innate immunity with an aggressive strategy to develop early stage programs for powerful new antiviral and immune modulating drugs. We believe our unique approach will yield a new class of drugs to respond to diseases caused by viruses such as, Influenza, Hepatitis C and West Nile virus: diseases that afflict millions of people.</p>","image":{"available_sizes":[[[150,37],"assets/images/resized/0007/2600/72600v1-max-150x150.png"],[[250,62],"assets/images/resized/0007/2600/72600v1-max-250x250.png"],[[253,63],"assets/images/resized/0007/2600/72600v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$942k","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.sec.gov/Archives/edgar/data/1479365/000147936510000001/xslFormDX01/primary_doc.xml","source_description":"SEC D","raised_amount":942455,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":7,"investments":[]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"307 Westlake Ave North","address2":"Suite 200","zip_code":"98109","city":"Seattle","state_code":"WA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}